Literature DB >> 27323706

Ectrodactyly and Lethal Pulmonary Acinar Dysplasia Associated with Homozygous FGFR2 Mutations Identified by Exome Sequencing.

Christopher P Barnett1,2, Nathalie J Nataren2,3,4, Manuela Klingler-Hoffmann2,3,4, Quenten Schwarz4, Chan-Eng Chong3, Young K Lee3, Damien L Bruno5, Jill Lipsett6, Andrew J McPhee7,8, Andreas W Schreiber2,4,9, Jinghua Feng2,4,9, Christopher N Hahn3,4,7, Hamish S Scott2,3,4,7,9.   

Abstract

Ectrodactyly/split hand-foot malformation is genetically heterogeneous with more than 100 syndromic associations. Acinar dysplasia is a rare congenital lung lesion of unknown etiology, which is frequently lethal postnatally. To date, there have been no reports of combinations of these two phenotypes. Here, we present an infant from a consanguineous union with both ectrodactyly and autopsy confirmed acinar dysplasia. SNP array and whole-exome sequencing analyses of the affected infant identified a novel homozygous Fibroblast Growth Factor Receptor 2 (FGFR2) missense mutation (p.R255Q) in the IgIII domain (D3). Expression studies of Fgfr2 in development show localization to the affected limbs and organs. Molecular modeling and genetic and functional assays support that this mutation is at least a partial loss-of-function mutation, and contributes to ectrodactyly and acinar dysplasia only in homozygosity, unlike previously reported heterozygous activating FGFR2 mutations that cause Crouzon, Apert, and Pfeiffer syndromes. This is the first report of mutations in a human disease with ectrodactyly with pulmonary acinar dysplasia and, as such, homozygous loss-of-function FGFR2 mutations represent a unique syndrome.
© 2016 WILEY PERIODICALS, INC.

Entities:  

Keywords:  FGFR2; acinar dysplasia; ectrodactyly; whole-exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 27323706     DOI: 10.1002/humu.23032

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

Review 1.  Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders.

Authors:  Marie Vincent; Justyna A Karolak; Gail Deutsch; Tomasz Gambin; Edwina Popek; Bertrand Isidor; Przemyslaw Szafranski; Cedric Le Caignec; Paweł Stankiewicz
Journal:  Am J Respir Crit Care Med       Date:  2019-11-01       Impact factor: 21.405

2.  Neonatal Lung Disease Associated with TBX4 Mutations.

Authors:  Kristen Suhrie; Nathan M Pajor; Shawn K Ahlfeld; D Brian Dawson; Kevin R Dufendach; Joseph A Kitzmiller; Daniel Leino; Rachel C Lombardo; Teresa A Smolarek; Pamela A Rathbun; Jeffrey A Whitsett; Christopher Towe; Kathryn A Wikenheiser-Brokamp
Journal:  J Pediatr       Date:  2018-11-07       Impact factor: 4.406

Review 3.  Interstitial lung disease in newborns.

Authors:  Lawrence M Nogee
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-28       Impact factor: 3.926

4.  Complex Compound Inheritance of Lethal Lung Developmental Disorders Due to Disruption of the TBX-FGF Pathway.

Authors:  Justyna A Karolak; Marie Vincent; Gail Deutsch; Tomasz Gambin; Benjamin Cogné; Olivier Pichon; Francesco Vetrini; Heather C Mefford; Jennifer N Dines; Katie Golden-Grant; Katrina Dipple; Amanda S Freed; Kathleen A Leppig; Megan Dishop; David Mowat; Bruce Bennetts; Andrew J Gifford; Martin A Weber; Anna F Lee; Cornelius F Boerkoel; Tina M Bartell; Catherine Ward-Melver; Thomas Besnard; Florence Petit; Iben Bache; Zeynep Tümer; Marie Denis-Musquer; Madeleine Joubert; Jelena Martinovic; Claire Bénéteau; Arnaud Molin; Dominique Carles; Gwenaelle André; Eric Bieth; Nicolas Chassaing; Louise Devisme; Lara Chalabreysse; Laurent Pasquier; Véronique Secq; Massimiliano Don; Maria Orsaria; Chantal Missirian; Jérémie Mortreux; Damien Sanlaville; Linda Pons; Sébastien Küry; Stéphane Bézieau; Jean-Michel Liet; Nicolas Joram; Tiphaine Bihouée; Daryl A Scott; Chester W Brown; Fernando Scaglia; Anne Chun-Hui Tsai; Dorothy K Grange; John A Phillips; Jean P Pfotenhauer; Shalini N Jhangiani; Claudia G Gonzaga-Jauregui; Wendy K Chung; Galen M Schauer; Mark H Lipson; Catherine L Mercer; Arie van Haeringen; Qian Liu; Edwina Popek; Zeynep H Coban Akdemir; James R Lupski; Przemyslaw Szafranski; Bertrand Isidor; Cedric Le Caignec; Paweł Stankiewicz
Journal:  Am J Hum Genet       Date:  2019-01-10       Impact factor: 11.025

5.  FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma.

Authors:  James M Cleary; Srivatsan Raghavan; Qibiao Wu; Yvonne Y Li; Liam F Spurr; Hersh V Gupta; Douglas A Rubinson; Isobel J Fetter; Jason L Hornick; Jonathan A Nowak; Giulia Siravegna; Lipika Goyal; Lei Shi; Lauren K Brais; Maureen Loftus; Atul B Shinagare; Thomas A Abrams; Thomas E Clancy; Jiping Wang; Anuj K Patel; Franck Brichory; Anne Vaslin Chessex; Ryan J Sullivan; Rachel B Keller; Sarah Denning; Emma R Hill; Geoffrey I Shapiro; Anna Pokorska-Bocci; Claudio Zanna; Kimmie Ng; Deborah Schrag; Pasi A Jänne; William C Hahn; Andrew D Cherniack; Ryan B Corcoran; Matthew Meyerson; Antoine Daina; Vincent Zoete; Nabeel Bardeesy; Brian M Wolpin
Journal:  Cancer Discov       Date:  2021-04-29       Impact factor: 39.397

6.  Copy-number variants and candidate gene mutations in isolated split hand/foot malformation.

Authors:  Tonia C Carter; Robert J Sicko; Denise M Kay; Marilyn L Browne; Paul A Romitti; Zoё L Edmunds; Aiyi Liu; Ruzong Fan; Charlotte M Druschel; Michele Caggana; Lawrence C Brody; James L Mills
Journal:  J Hum Genet       Date:  2017-05-25       Impact factor: 3.172

Review 7.  Review: Understanding Rare Genetic Diseases in Low Resource Regions Like Jammu and Kashmir - India.

Authors:  Arshia Angural; Akshi Spolia; Ankit Mahajan; Vijeshwar Verma; Ankush Sharma; Parvinder Kumar; Manoj Kumar Dhar; Kamal Kishore Pandita; Ekta Rai; Swarkar Sharma
Journal:  Front Genet       Date:  2020-04-30       Impact factor: 4.599

8.  AutoMap is a high performance homozygosity mapping tool using next-generation sequencing data.

Authors:  Mathieu Quinodoz; Virginie G Peter; Nicola Bedoni; Béryl Royer Bertrand; Katarina Cisarova; Arash Salmaninejad; Neda Sepahi; Raquel Rodrigues; Mehran Piran; Majid Mojarrad; Alireza Pasdar; Ali Ghanbari Asad; Ana Berta Sousa; Luisa Coutinho Santos; Andrea Superti-Furga; Carlo Rivolta
Journal:  Nat Commun       Date:  2021-01-22       Impact factor: 14.919

9.  Phenotypic spectrum of FGF10-related disorders: a systematic review.

Authors:  Katarzyna Bzdega; Justyna A Karolak
Journal:  PeerJ       Date:  2022-09-14       Impact factor: 3.061

Review 10.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.